130 related articles for article (PubMed ID: 32261945)
1. Bisphosphonate-polyaspartamide conjugates as bone targeted drug delivery systems.
Paolino D; Licciardi M; Celia C; Giammona G; Fresta M; Cavallaro G
J Mater Chem B; 2015 Jan; 3(2):250-259. PubMed ID: 32261945
[TBL] [Abstract][Full Text] [Related]
2. Nanoaggregates based on new poly-hydroxyethyl-aspartamide copolymers for oral insulin absorption.
Licciardi M; Pitarresi G; Cavallaro G; Giammona G
Mol Pharm; 2013 May; 10(5):1644-54. PubMed ID: 23331253
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and characterization of thiomers of polyaspartamide type.
Bilicić MB; Filipović-Grcić J; Martinac A; Barbarić M; Zorc B; Cetina-Cizmek B; Tudja P
Int J Pharm; 2005 Mar; 291(1-2):211-9. PubMed ID: 15707748
[TBL] [Abstract][Full Text] [Related]
4. Folate-mediated targeting of polymeric conjugates of gemcitabine.
Cavallaro G; Licciardi M; Salmaso S; Caliceti P; Gaetano G
Int J Pharm; 2006 Jan; 307(2):258-69. PubMed ID: 16298091
[TBL] [Abstract][Full Text] [Related]
5. Macromolecular prodrugs. XIII. Hydrosoluble conjugates of 17β-estradiol and estradiol-17β-valerate with polyaspartamide polymer.
Končič MZ; Zorc B; Novak P
Acta Pharm; 2011 Dec; 61(4):465-72. PubMed ID: 22202205
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of poly(alpha,beta-[N-(2-hydroxyethyl)-L-aspartamide])-folate for drug delivery.
Zou T; Li SL; Cheng SX; Zhang XZ; Zhuo RX
J Biomater Sci Polym Ed; 2010; 21(6-7):759-70. PubMed ID: 20482983
[TBL] [Abstract][Full Text] [Related]
7. Polyaspartamide-doxorubicin conjugate as potential prodrug for anticancer therapy.
Di Meo C; Cilurzo F; Licciardi M; Scialabba C; Sabia R; Paolino D; Capitani D; Fresta M; Giammona G; Villani C; Matricardi P
Pharm Res; 2015 May; 32(5):1557-69. PubMed ID: 25366547
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and characterization of polyaminoacidic polycations for gene delivery.
Licciardi M; Campisi M; Cavallaro G; Cervello M; Azzolina A; Giammona G
Biomaterials; 2006 Mar; 27(9):2066-75. PubMed ID: 16233912
[TBL] [Abstract][Full Text] [Related]
9. Poly-alpha,beta-(N-(2-hydroxyethyl)-L-aspartamide)-g-poly(1,3trimethylene carbonate) amphiphilic graft co-polymer as a potential drug carrier.
Peng T; Su J; Cheng SX; Zhuo RX
J Biomater Sci Polym Ed; 2006; 17(8):941-51. PubMed ID: 17024882
[TBL] [Abstract][Full Text] [Related]
10. Macromolecular prodrugs. IX. Synthesis of polymer-fenoprofen conjugates.
Zovko M; Zorc B; Lovrek M; Boneschans B
Int J Pharm; 2001 Oct; 228(1-2):129-38. PubMed ID: 11576775
[TBL] [Abstract][Full Text] [Related]
11. Gemfibrozil encapsulation and release from microspheres and macromolecular conjugates.
Martinac A; Filipović-Grcić J; Barbarić M; Zorc B; Voinovich D; Jalsenjak I
Eur J Pharm Sci; 2002 Dec; 17(4-5):207-16. PubMed ID: 12453610
[TBL] [Abstract][Full Text] [Related]
12. Glycosylated macromolecular conjugates of antiviral drugs with a polyaspartamide.
Cavallaro G; Maniscalco L; Caliceti P; Salmaso S; Semenzato A; Giammona G
J Drug Target; 2004; 12(9-10):593-605. PubMed ID: 15621685
[TBL] [Abstract][Full Text] [Related]
13. Realization of polyaspartamide-based nanoparticles and in vivo lung biodistribution evaluation of a loaded glucocorticoid after aerosolization in mice.
Craparo EF; Di Gioia S; Trapani A; Cellamare S; Belgiovine G; Mandracchia D; Giammona G; Cavallaro G; Conese M
Int J Pharm; 2016 Aug; 510(1):263-70. PubMed ID: 27326484
[TBL] [Abstract][Full Text] [Related]
14. Fluoropolymer based on a polyaspartamide containing 1,2,4-oxadiazole units: a potential artificial oxygen (O2) carrier.
Mandracchia D; Piccionello AP; Pitarresi G; Pace A; Buscemi S; Giammona G
Macromol Biosci; 2007 Jun; 7(6):836-45. PubMed ID: 17541930
[TBL] [Abstract][Full Text] [Related]
15. PHEA-PLA biocompatible nanoparticles by technique of solvent evaporation from multiple emulsions.
Cavallaro G; Craparo EF; Sardo C; Lamberti G; Barba AA; Dalmoro A
Int J Pharm; 2015 Nov; 495(2):719-27. PubMed ID: 26410757
[TBL] [Abstract][Full Text] [Related]
16. Macromolecular prodrugs. XII. Primaquine conjugates: synthesis and preliminary antimalarial evaluation.
Rajić Z; Kos G; Zorc B; Singh PP; Singh S
Acta Pharm; 2009 Mar; 59(1):107-15. PubMed ID: 19304563
[TBL] [Abstract][Full Text] [Related]
17. Reversibly stable thiopolyplexes for intracellular delivery of genes.
Cavallaro G; Campisi M; Licciardi M; Ogris M; Giammona G
J Control Release; 2006 Oct; 115(3):322-34. PubMed ID: 17028038
[TBL] [Abstract][Full Text] [Related]
18. A hydrogel based on a polyaspartamide: characterization and evaluation of in-vivo biocompatibility and drug release in the rat.
Giammona G; Pitarresi G; Tomarchio V; Cacciaguerra S; Govoni P
J Pharm Pharmacol; 1997 Nov; 49(11):1051-6. PubMed ID: 9401936
[TBL] [Abstract][Full Text] [Related]
19. Antitumor activity and toxicological properties of doxorubicin conjugated to [alpha],[beta]-poly[(2-hydroxyethyl)-L-aspartamide] administered intraperitoneally in mice.
Cheng C; Xue W; Diao H; Xia S; Zuo L; He A; Gao F; Huang Z; Chen J; Zhang J
Anticancer Drugs; 2010 Apr; 21(4):362-71. PubMed ID: 20468087
[TBL] [Abstract][Full Text] [Related]
20. Modulation of physical and biological properties of a composite PLLA and polyaspartamide derivative obtained via thermally induced phase separation (TIPS) technique.
Carfì Pavia F; Palumbo FS; La Carrubba V; Bongiovì F; Brucato V; Pitarresi G; Giammona G
Mater Sci Eng C Mater Biol Appl; 2016 Oct; 67():561-569. PubMed ID: 27287155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
